Latest filing published 12 May 2023 for AbbVie Inc., €386k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Carrie C. Strom (senior executive) discloses dealings in AbbVie Inc. to SEC (Form 4). Over a trading history stretching from 3 May 2021 to 11 May 2023, the count stands at 25 filings.
The open-market record consists of 7 sales worth €4.6M, with no purchase. Besides market trades, the filings include 15 share grants and 3 option exercises. So far in 2023, the count stands at no purchases and 6 sales.
Most recently, on 12 May 2023, the filings show a share grant worth €386k in AbbVie Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 25 declarations